Related Experiment Videos
Plasmapheresis-induced remission in otherwise therapy-resistant FSGS.
A K Vécsei1, T Müller, E C Schratzberger
1St. Anna Kinderspital, Kinderspitalgasse 6, 1090 Vienna, Austria.
Pediatric Nephrology (Berlin, Germany)
|October 31, 2001
Summary
This case study highlights a child with difficult-to-treat nephrotic syndrome. Plasma exchange therapy successfully induced remission when other treatments failed, suggesting its potential role in managing resistant cases.
Area of Science:
- Pediatric Nephrology
- Glomerular Diseases
Background:
- Steroid-resistant nephrotic syndrome (SRNS) presents a significant therapeutic challenge in pediatric patients.
- Focal segmental glomerulosclerosis (FSGS) is a common cause of SRNS, often progressing despite standard treatments.
Observation:
- An 8-year-old boy with biopsy-proven cellular FSGS exhibited resistance to multiple immunosuppressive therapies, including cyclosporine A and mycophenolate mofetil.
- Despite a year of intensive treatment, the patient's condition remained refractory.
Findings:
- Five sessions of plasma exchange therapy led to complete remission of nephrotic syndrome.
- This outcome suggests plasma exchange can be effective in cases unresponsive to conventional management.
Implications:
- Aggressive therapeutic strategies, including plasma exchange, should be considered for children with refractory SRNS.
- Plasma exchange warrants inclusion as a potential rescue therapy in future clinical trial protocols for resistant FSGS.